Abstract
Both addiction and chronic pain disorders are common. The use of opioids for chronic pain management may trigger the addictive process in biogenetically vulnerable patients, with potential consequences to the individual and society. Therefore, pain clinicians need to screen for risk factors for addiction and use a consistent approach to prescribing and monitoring opioid therapy. Some patients with both disorders require a collaborative approach from experts in pain and addiction to optimize outcomes and reduce risks.
| Original language | English |
|---|---|
| Title of host publication | Clinical Pain Management |
| Subtitle of host publication | A Practical Guide |
| Editors | M. Lynch, K. Craig, P. Peng |
| Place of Publication | Oxford |
| Publisher | Wiley-Blackwell |
| Pages | 326-334 |
| Number of pages | 9 |
| ISBN (Print) | 9781444330694 |
| DOIs | |
| State | Published - 2010 |
Keywords
- "an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage"
- American Association on Intellectual and Developmental Disabilities (AAIDD)
- Defining ID and conceptual issues
- International Association for the Study of Pain (IASP)
- Non-pharmacological management approaches
- Pain in individuals with intellectual disabilities
- Pain sources and risk factors
- Scope of the problem of pain in individuals with ID
- Therapeutic failure and drug interactions
- World Health Organization (WHO)